Clinical Trial Update: Brachytherapy With Radiotherapy and Immunotherapy: Guided HDR Trial in Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating brachytherapy with radiotherapy and immunotherapy for esophageal squamous cell carcinoma, sponsored by National Taiwan Univers…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Esophageal Cancer, Esophageal Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING